CoLucid Pharmaceuticals, Inc. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CoLucid Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CoLucid Pharmaceuticals, Inc. for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | LILLY ELI & CO | 10% Owner | Buy | J | 46.50 | 19,285,108 | 896,757,522 | 100 | -19,285,008 to 100 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | PAPPAS ARTHUR M | Director | Option Exercise | D | 6.24 | 8,897 | 55,517 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | PAPPAS ARTHUR M | Director | Option Exercise | D | 10.00 | 5,954 | 59,540 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | PAPPAS ARTHUR M | Director | Sell | U | 46.50 | 5,528 | 257,052 | 0 | 5.5 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | PAPPAS ARTHUR M | Director | Sell | U | 46.50 | 116,317 | 5,408,741 | 0 | 116.3 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | PAPPAS ARTHUR M | Director | Sell | U | 46.50 | 1,871,049 | 87,003,779 | 0 | 1.9 M to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | White Marvin L | Director | Option Exercise | D | 36.20 | 453 | 16,399 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | White Marvin L | Director | Option Exercise | D | 9.62 | 1,630 | 15,681 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | White Marvin L | Director | Option Exercise | D | 6.24 | 8,897 | 55,517 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | White Marvin L | Director | Option Exercise | D | 8.50 | 997 | 8,475 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | White Marvin L | Director | Option Exercise | D | 8.60 | 6,577 | 56,562 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Skwierczynski Raymond | Head,Pharmaceutical ... | Option Exercise | D | 6.75 | 15,000 | 101,250 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Skwierczynski Raymond | Head,Pharmaceutical ... | Option Exercise | D | 5.69 | 90,000 | 512,100 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Skwierczynski Raymond | Head,Pharmaceutical ... | Sell | U | 46.50 | 3,615 | 168,098 | 0 | 3.6 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Mathers Thomas P. | Chief Executive Off ... | Option Exercise | D | 0.00 | 105,147 | 0 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Mathers Thomas P. | Chief Executive Off ... | Option Exercise | D | 6.75 | 83,000 | 560,250 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Mathers Thomas P. | Chief Executive Off ... | Option Exercise | D | 10.00 | 360,508 | 3,605,080 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Mathers Thomas P. | Chief Executive Off ... | Sell | D | 46.50 | 83,000 | 3,859,500 | 0 | 83 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Mathers Thomas P. | Chief Executive Off ... | Sell | U | 46.50 | 173,519 | 8,068,634 | 0 | 173.5 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Option Exercise | D | 36.20 | 658 | 23,820 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Option Exercise | D | 9.62 | 2,371 | 22,809 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Option Exercise | D | 6.24 | 8,897 | 55,517 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Option Exercise | D | 8.50 | 1,449 | 12,317 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Option Exercise | D | 10.00 | 5,954 | 59,540 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Marengere Luc | Director | Sell | U | 46.50 | 1,545,386 | 71,860,449 | 0 | 1.5 M to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Lawton Alison Frances | Director | Option Exercise | D | 36.20 | 658 | 23,820 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Lawton Alison Frances | Director | Option Exercise | D | 6.24 | 8,897 | 55,517 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Lawton Alison Frances | Director | Option Exercise | D | 6.54 | 1,420 | 9,287 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Kuca Bernice | Head,Clin. and Reg. ... | Option Exercise | D | 6.75 | 37,500 | 253,125 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Kuca Bernice | Head,Clin. and Reg. ... | Option Exercise | D | 10.00 | 270,381 | 2,703,810 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Kuca Bernice | Head,Clin. and Reg. ... | Sell | D | 46.50 | 37,500 | 1,743,750 | 0 | 37.5 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Kuca Bernice | Head,Clin. and Reg. ... | Sell | U | 46.50 | 2,729 | 126,899 | 0 | 2.7 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Hogan Linda C. | Head, Bus. Dev. and ... | Option Exercise | D | 6.75 | 26,594 | 179,510 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Hogan Linda C. | Head, Bus. Dev. and ... | Option Exercise | D | 7.56 | 5,741 | 43,402 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Hogan Linda C. | Head, Bus. Dev. and ... | Option Exercise | D | 10.00 | 46,966 | 469,660 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 6.75 | 37,500 | 253,125 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 7.56 | 30,000 | 226,800 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Option Exercise | D | 10.00 | 180,254 | 1,802,540 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | D | 46.50 | 37,500 | 1,743,750 | 0 | 37.5 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | Dallas Matthew D | Chief Financial Off ... | Sell | U | 46.50 | 2,708 | 125,922 | 0 | 2.7 K to 0 (-100.00 %) |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | CORRIGAN MARK | Director | Option Exercise | D | 6.24 | 8,897 | 55,517 | 0 | |
| Mar 01 2017 | CLCD | CoLucid Pharmaceut ... | CORRIGAN MARK | Director | Option Exercise | D | 3.79 | 8,114 | 30,752 | 0 |